[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350856-105":59,"doc-detail-350856-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","a-compendium-of-next-generation-patient-derived-models-for-diverse-cancers","A compendium of next-generation patient-derived models for diverse cancers","","Development of new therapeutics depends on representative laboratory models that reflect patient tumors and disease mechanisms. Existing cancer model collections capture only part of observed human diversity, and it remains unclear whether modern derivation methods preserve key tumor properties during long-term expansion. A large international Human Cancer Models Initiative generated 665 next-generation models spanning 25 cancer types, with multi-omics profiling, clinical data, and analyses of tumor–model concordance.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/a-compendium-of-next-generation-patient-derived-models-for-diverse-cancers/350856/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/a-compendium-of-next-generation-patient-derived-models-for-diverse-cancers/350856.png","ImageObject",300,407,{"name":92,"@type":93},"moss~","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-24","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What problem does the study address in current cancer model collections?","Question",{"text":112,"@type":113},"Existing collections capture only a portion of the diversity seen across human cancers, and many models have unclear fidelity to the originating tumor specimen and limited clinical information.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the Human Cancer Models Initiative resource constructed?",{"text":117,"@type":113},"The program generated 665 next-generation patient-derived models from 2,780 donors covering 25 cancer types, integrating multimodal whole-genome, exome, methylome, and transcriptome analyses with clinical data.",{"name":119,"@type":110,"acceptedAnswer":120},"What do the analyses show about how well models match patient tumors?",{"text":121,"@type":113},"Analyses of matched tumor–model pairs report high genetic concordance (97.8%) and epigenetic concordance (95%), along with defined correlates of model discordance.",{"name":123,"@type":110,"acceptedAnswer":124},"How do the models support studies of treatment response and resistance?",{"text":125,"@type":113},"The study characterizes model preservation of extrachromosomal DNA and post-treatment mutational signatures, enabling opportunities to investigate therapeutic resistance and treatment effects.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},350856,1790695815,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":143,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":24,"preview_urls":150},962090895452,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \n\n| A compendium of next-generation\u003Cbr>patient-derived models for diverse cancers |  |  |\n| --- | --- | --- |\n| [https://doi.org/10.1038/s41586-026-10806-y](https://doi.org/10.1038/s41586-026-10806-y)\u003Cbr>Received: 8 February 2025 Accepted: 22 May 2026 Published online: 5 August 2026 Open access\u003Cbr> Check for updates | Dina ElHarouni1,2,73, Mushriq Al-Jazrawe1,3,73, Seongmin Choi4,5,73, Merve Dede6,73,\u003Cbr>Toshinori Hinoue7,73, Sean A. Misek1,8,73, Heeju Noh9,10,73, Luca Zanella9,73, Yuen-Yi Tseng1, Hayley E. Francies11, Dennis Plenker12, Cindy W. Kyi13, Julyann Perez-Mayoral13, Megan J. Stine14, Eva Tonsing-Carter13, Rachana Agarwal15, Jean Claude Zenklusen13, James M. Clinton16, Jennifer M. Shelton17, Timothy R. Chu17, William F. Hooper17, Xavi Loinaz1,18, Paula Keskula1, Jordan Tagle19, Peyton C. Kuhlers20, Bahar Tercan10, Sylvia F. Boj21, Alessandro Vasciaveo22, Lorenzo Tomassoni9,23, James M. Crawford24, Shawna Walsh2, Claire Sinai2, Sonam Bhatia2,12, Priya Sridevi12, Hardik Patel12, Maria Antonietta Cerone25, The HCMI Network*, Kyle Ellrott19, Calvin J. Kuo26, Olivier Elemento27, Semir Beyaz12, Vincenzo Corbo28, David L. Spector12, Rameen Beroukhim1,8, Martin L. Ferguson13, Andrew D. Cherniack1,8, Peter W. Laird7,\u003Cbr>Nicolas Robine17, Andrew McPherson4,5, Katherine A. Hoadley20, Mathew J. Garnett11,74, David A. Tuveson12,74, Andrea Califano9,29,30,31,32,33,74, Paul T. Spellman34,74, Keith L. Ligon1,2,35,36,74✉, Daniela S. Gerhard13,74, Louis M. Staudt37,74✉ & Jesse S. Boehm1,3,74✉\u003Cbr>The development of new therapeuticsand the validation of pathogenetic cancer mechanisms require representative laboratory models1,2. However, existing collections represent only a fraction of the diversity observed inhuman cancer2–4. Recent technologies have enabled efficient in vitro model derivation (for example, tumour organoids)5. However, whether these maintain essential properties of patient tumours during long-term expansion has not been systematically investigated. Here we present resultsofa large-scale international programme—the Human Cancer Models Initiative—which involved the generation of a resource of 665 next-generation models from 2,780 donors with 25 cancer types and integrated tumour–model whole genome, exome, methylome and transcriptome analyses. The resource provides 522 models with comprehensive clinical data, 153 models of rare cancersand 71 models from participants with non-European ancestry. Analyses of 421 matched tumour– model pairs reveal high genetic (97.8%) and epigenetic (95%) concordance and define correlates of model discordance. Single-nucleus RNA sequencing of tumour–model pairs reveals subsets of models in which culture conditions significantly influence cell states. Finally, we characterize model preservation of extrachromosomal DNA and post-treatment mutational signatures to provide opportunities to study therapeutic resistance. This model repository is being made available to the community—including multimodal molecular profiling, clinical information and integrative software tools—thus providing a valuable resource for preclinical investigation of cancer pathogenesis and treatment response. |  |\n| Major international projects have generated cancer atlases3,6 that have revealed many molecular underpinnings of human malignancies7–9. Provocative hypotheses about most types of cancer have emerged, with each requiring preclinical validation to support both basic science and drug discovery. Well-characterized cancer models that maintain the fidelity of diverse human tumour types and clinical states are required for such validation10.\u003Cbr>Efforts to genomically characterize large cohorts of cancer modelshave produced comprehensively annotated compendia of over 1,000 cell lines1,2,11,12, which have enabled large-scale mapping of cancer dependencies9,13–16. However, existing cell lines typically exhibit limited |  | phenotypic complexity, uncertain fidelity to the originating tumour specimen and inadequate","cbCaitAjNJomnjxP","https://ap.wps.com/l/cbCaitAjNJomnjxP","pdf",56943495,44,"English","# The need for representative cancer models\n## Limits of existing model collections\n# Human Cancer Models Initiative resource\n## Model generation and scope\n## Clinical and multimodal data\n# Genomic, epigenomic, and transcriptomic analyses\n## Concordance in matched tumor–model pairs\n## Single-nucleus RNA sequencing findings\n# Translational and clinical utility\n## Extrachromosomal DNA and mutational signatures\n## Availability to the research community","[{\"question\":\"What problem does the study address in current cancer model collections?\",\"answer\":\"Existing collections capture only a portion of the diversity seen across human cancers, and many models have unclear fidelity to the originating tumor specimen and limited clinical information.\"},{\"question\":\"How was the Human Cancer Models Initiative resource constructed?\",\"answer\":\"The program generated 665 next-generation patient-derived models from 2,780 donors covering 25 cancer types, integrating multimodal whole-genome, exome, methylome, and transcriptome analyses with clinical data.\"},{\"question\":\"What do the analyses show about how well models match patient tumors?\",\"answer\":\"Analyses of matched tumor–model pairs report high genetic concordance (97.8%) and epigenetic concordance (95%), along with defined correlates of model discordance.\"},{\"question\":\"How do the models support studies of treatment response and resistance?\",\"answer\":\"The study characterizes model preservation of extrachromosomal DNA and post-treatment mutational signatures, enabling opportunities to investigate therapeutic resistance and treatment effects.\"}]","A compendium of next-generation patient-derived models for diverse cancers | PDF",1790091525,111,[151,155,159,163,167],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9941132eda7ec0a8ce77c9d04a42edd4.webp",983,1305,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb79a49a50f8705078dbb078a38fea3e.webp",982,1304,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec49af3fac2887eb294a753c016606e5.webp",981,1303,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/22ef5fde79a87345c248e5d6a50c70bb.webp",980,1301,{"page_no":24,"url":168,"width":169,"height":170},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e031c92c5a3a7f3d7751fa37c9bb870c.webp",979,1300]